As Celgene (CELG) Market Value Declined, Etrade Capital Management Has Lowered by $358,384 Its Holding; As Jpmorgan Chase & Co (JPM) Market Value Rose, Brown Advisory Securities Has Boosted Position

JPMorgan Chase & Co. (NYSE:JPM) Logo

Brown Advisory Securities Llc increased its stake in Jpmorgan Chase & Co (JPM) by 5.71% based on its latest 2017Q4 regulatory filing with the SEC. Brown Advisory Securities Llc bought 3,472 shares as the company’s stock rose 0.67% while stock markets declined. The institutional investor held 64,245 shares of the major banks company at the end of 2017Q4, valued at $6.87 million, up from 60,773 at the end of the previous reported quarter. Brown Advisory Securities Llc who had been investing in Jpmorgan Chase & Co for a number of months, seems to be bullish on the $375.04B market cap company. The stock increased 1.82% or $1.97 during the last trading session, reaching $109.97. About 13.27 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 23.99% since April 1, 2017 and is uptrending. It has outperformed by 12.44% the S&P500.

Etrade Capital Management Llc decreased its stake in Celgene Corp (CELG) by 11.94% based on its latest 2017Q4 regulatory filing with the SEC. Etrade Capital Management Llc sold 3,446 shares as the company’s stock declined 19.30% with the market. The institutional investor held 25,424 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.65M, down from 28,870 at the end of the previous reported quarter. Etrade Capital Management Llc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $67.10B market cap company. The stock increased 0.90% or $0.8 during the last trading session, reaching $89.21. About 7.59M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 1, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 13 Hold. Therefore 56% are positive. Celgene Corporation has $190 highest and $83 lowest target. $131.28’s average target is 47.16% above currents $89.21 stock price. Celgene Corporation had 140 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, September 29 by Citigroup. The stock of Celgene Corporation (NASDAQ:CELG) earned “Hold” rating by Bank of America on Friday, January 5. The rating was upgraded by Argus Research to “Buy” on Monday, July 31. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, July 6. RBC Capital Markets maintained Celgene Corporation (NASDAQ:CELG) rating on Tuesday, January 23. RBC Capital Markets has “Buy” rating and $142.0 target. The stock has “Hold” rating by Piper Jaffray on Thursday, December 21. The company was initiated on Monday, October 23 by Guggenheim. On Tuesday, November 8 the stock rating was initiated by Mizuho with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Friday, June 23 by Jefferies. The stock has “Buy” rating by SunTrust on Monday, January 8.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It dived, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. 21,504 are owned by Paloma Management. Halsey Incorporated Ct reported 155,399 shares. Estabrook Cap Mgmt reported 300 shares stake. Main Street Rech Ltd Liability reported 11,293 shares stake. Glenmede Tru Na stated it has 780,047 shares. Gw Henssler And Assocs Ltd reported 163,077 shares stake. Rafferty Asset Mgmt Ltd Limited Liability Company invested 0.02% of its portfolio in Celgene Corporation (NASDAQ:CELG). Brown Brothers Harriman & holds 0.01% in Celgene Corporation (NASDAQ:CELG) or 9,354 shares. Df Dent And has 1.64% invested in Celgene Corporation (NASDAQ:CELG) for 622,827 shares. Mercer Capital Advisers accumulated 1,690 shares. Great West Life Assurance Communication Can owns 734,914 shares. Caprock Gp owns 0.12% invested in Celgene Corporation (NASDAQ:CELG) for 5,774 shares. Winch Advisory Services Ltd Limited Liability Company accumulated 13,500 shares. Profit Investment Management Limited Liability Corp holds 0.97% or 12,208 shares in its portfolio. Signature Est Advsrs Limited Liability Corp owns 1,371 shares or 0.01% of their US portfolio.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. They expect $1.78 earnings per share, up 16.34% or $0.25 from last year’s $1.53 per share. CELG’s profit will be $1.34 billion for 12.53 P/E if the $1.78 EPS becomes a reality. After $1.87 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -4.81% negative EPS growth.

Etrade Capital Management Llc, which manages about $2.37B and $3.12B US Long portfolio, upped its stake in Ishares Russell 2000 Value Etf (IWN) by 14,977 shares to 538,045 shares, valued at $67.66M in 2017Q4, according to the filing. It also increased its holding in Spdr S&P 500 Etf Trust (SPY) by 23,724 shares in the quarter, for a total of 1.04M shares, and has risen its stake in Pepsico Inc (NYSE:PEP).

Since February 8, 2018, it had 1 insider purchase, and 3 selling transactions for $3.58 million activity. On Monday, March 12 the insider LOUGHLIN JAMES J sold $851,093. MARIO ERNEST sold $1.26M worth of stock. The insider Alles Mark J bought $299,594.

Brown Advisory Securities Llc, which manages about $869.60M and $518.58M US Long portfolio, decreased its stake in Verizon Communications Inc (NYSE:VZ) by 13,008 shares to 71,576 shares, valued at $3.78 million in 2017Q4, according to the filing. It also reduced its holding in Vanguard Index Fds (VNQ) by 6,813 shares in the quarter, leaving it with 21,852 shares, and cut its stake in Vanguard Specialized Funds (VIG).

Among 33 analysts covering JPMorgan Chase & Co (NYSE:JPM), 18 have Buy rating, 2 Sell and 13 Hold. Therefore 55% are positive. JPMorgan Chase & Co has $136 highest and $52 lowest target. $103.68’s average target is -5.72% below currents $109.97 stock price. JPMorgan Chase & Co had 114 analyst reports since July 21, 2015 according to SRatingsIntel. On Monday, February 22 the stock rating was downgraded by Portales Partners to “Underperform”. The rating was upgraded by Keefe Bruyette & Woods on Tuesday, February 13 to “Buy”. Oppenheimer maintained the shares of JPM in report on Friday, July 14 with “Hold” rating. As per Tuesday, August 16, the company rating was downgraded by Bernstein. Keefe Bruyette & Woods maintained JPMorgan Chase & Co. (NYSE:JPM) on Wednesday, October 14 with “Outperform” rating. The firm has “Buy” rating given on Friday, July 7 by Jefferies. The rating was maintained by BMO Capital Markets on Friday, October 13 with “Market Perform”. The rating was maintained by Goldman Sachs on Thursday, July 6 with “Neutral”. The firm has “Buy” rating given on Friday, January 12 by RBC Capital Markets. The stock has “Buy” rating by Credit Suisse on Wednesday, January 24.

JPMorgan Chase & Co. (NYSE:JPM) Institutional Positions Chart